Showing results (51-60 of 177) with videos related to
Sort By:
Pageof 18
Expert Opinion on Biological Therapy|November 1, 2024
The future of cellular therapy for the treatment of renal cell carcinomaNada Chaoul, Eleonora Lauricella, Andrea Giglio, et al.Cellular Signalling|February 6, 2013
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastropheMauro Cives, Sabino Ciavarella, Francesca Maria Rizzo, et al.The Oncologist|December 10, 2020
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?Elettra Merola, Teresa Alonso Gordoa, Panpan Zhang, et al.The Oncologist|November 23, 2020
Efficacy of FOLFOX in Patients with Aggressive Pancreatic Neuroendocrine Tumors After Prior Capecitabine/TemozolomideTaymeyah Al-Toubah, Brian Morse, Eleonora Pelle, et al.Journal of the National Comprehensive Cancer Network : JNCCN|December 12, 2022
Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine TumorEleonora Pelle, Taymeyah Al-Toubah, Brian Morse, et al.Journal of Neuroendocrinology|September 7, 2024
PRRT in high-grade digestive neuroendocrine neoplasms (NET G3 and NEC)Halfdan Sorbye, Grace Kong, Simona Grozinsky-Glasberg, et al.Annals of Surgical Oncology|October 1, 2025
Association Between Long-Term Proton Pump Inhibitor Use and Low-Risk Gastric Neuroendocrine TumorsTaymeyah Al-Toubah, Eleonora Pelle, Mintallah Haider, et al.Neuroendocrinology|May 14, 2020
Bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical PracticeMauro Cives, Eleonora Pellè, Maria Rinzivillo, et al.Frontiers in Oncology|November 22, 2019
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic CellsMarco Tucci, Anna Passarelli, Francesco Mannavola, et al.Oxidative Medicine and Cellular Longevity|July 6, 2016
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal TransitionRaffaele Palmirotta, Mauro Cives, David Della-Morte, et al.Pageof 18